Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors

Yongxin Han1, André Giroux, John Colucci

  • 1Department of Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, Merck Frosst Canada & Co., PO Box 1005, Pointe-Claire-Dorval, Quebec, Canada H9R 4P8. yongxin_han@merck.com